drugset / Trial / NCT01670929

Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage

NCT01670929

Phase 4 Completed 700 enrolled Woman's Health University Hospital, Egypt
RandomizedParallel-groupDouble-blindTreatment

Summary

In women with unexplained recurrent miscarriages, progesterone (400 mg pessaries, twice daily), started soon as possible at luteal phase and after a positive pregnancy test and continued to 28 weeks of gestation, compared to placebo, ).

Timeline

Start
2012-09
Primary completion
2015-05
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 400 mg